Bayer and Nuvisan Collaborate to Establish a New Research Entity in Berlin

 Bayer and Nuvisan Collaborate to Establish a New Research Entity in Berlin

Bayer and Nuvisan Collaborate to Establish a New Research Entity in Berlin

Shots:

  • Bayer to transfer its small molecule research unit to Nuvisan for establishing a new research center in Berlin. The transaction is expected to close mid of 2020
  • The collaboration will strengthen the healthcare cluster in Berlin, accelerating the drug development process and supports Bayer to focus on the flexibility and productivity of its R&D operating model
  • The new research center will be a full-fledged research unit and will provide ~400 jobs in Berlin. Bayer retain its research activities in Berlin, which remains the HQ of its global research sites

Click here ­to­ read full press release/ article | Ref: Bayer | Image: Radar

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post